Advertisement

Topics

Pharma R&D Investments Moderating, But Still High

03:58 EDT 12 Jun 2018 | Forbes

However, it is clear that the pharmaceutical industry is going to continue to invest in R&D at a pretty healthy rate for the foreseeable future.

Original Article: Pharma R&D Investments Moderating, But Still High

NEXT ARTICLE

More From BioPortfolio on "Pharma R&D Investments Moderating, But Still High"

Advertisement
Quick Search
Advertisement
Advertisement